Latest filing published 16 Mar 2018 for Allergy Therapeutics Plc, €7,838.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -69.5%Entry £0.27 · Close at T+365 £0.08
- -48.3%Entry £0.38 · Close at T+365 £0.20
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Babatunde (Tunde) Otulana: trading record in brief
Babatunde (Tunde) Otulana is a declared insider of Allergy Therapeutics PLC, with filings sourced from RNS (LSE). The record holds 2 filings, for trades running from 11 October 2017 to 15 March 2018.
On the market, this insider has only ever bought: 2 purchases, €19k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2018 to date brings 1 purchase and no sales.
On 16 March 2018 came the latest disclosure, an open-market purchase for €7,838 in Allergy Therapeutics PLC. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Babatunde (Tunde) Otulana
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 25,000 shares@ US$0.38842.3% of flowUnited StatesISIN GB00B02LCQ05FCA-NSM:LSE20180316125305_13570403_20200330111427363_14394Canonical exit: 13 Jun 2018 (T+90)
- 25,000 shares@ US$0.506657.7% of flowUnited StatesFCA-NSM:LSE20171012145504_13395146_20200330131537739_8715Canonical exit: 9 Jan 2018 (T+90)
2 of 2 declarations